Post-infarction ventricular septal defect: risk factors and early outcomes

Hellenic J Cardiol. 2015 Jan-Feb;56(1):66-71.

Abstract

Introduction: Rupture of the ventricular septum complicates acute myocardial infarction in 0.2% of cases in the thrombolytic era. Ventricular septal defect (VSD) has a mortality of 90-95% in medically managed and 19-60% in surgically treated patients.

Methods: A retrospective analysis was performed of 41 patients, 26 females (63.4%) and 15 males (36.6%), average age 67.5 ± 15 years, with post-infarction VSD who were treated in the VUL SK intensive cardiology unit between 1991 and 2007.

Results: Thirty-seven patients had hypertension (90.2%); anterior wall acute myocardial infarction (AMI) was found in 27 patients (68%). VSD was more frequent in women than in men (p=0.043). In 36 patients (87%) treatment was started 24 hours or later after the development of AMI symptoms. In 34 patients (83%) the rupture occurred during the first episode of AMI and in the majority of these (19 patients, 46.3%), preoperative coronary angiography demonstrated disease of only one coronary artery. During the first 10 days after the onset of AMI, 5 patients (12.2%) were treated surgically but did not survive the operation; 33 patients (80.5%) underwent operation 3-4 weeks after the onset of AMI and all survived.

Conclusions: Female sex, advanced age, arterial hypertension, anterior wall AMI, absence of previous AMI, and late arrival at hospital are associated with a higher risk of mortality from acute VSD. The most important factor that determines operative mortality and intra-hospital survival is the time from the onset of AMI to operation.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anterior Wall Myocardial Infarction* / complications
  • Anterior Wall Myocardial Infarction* / diagnosis
  • Anterior Wall Myocardial Infarction* / mortality
  • Anterior Wall Myocardial Infarction* / therapy
  • Coronary Angiography / methods
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Hypertension / epidemiology
  • Lithuania / epidemiology
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Streptokinase* / administration & dosage
  • Streptokinase* / adverse effects
  • Survival Analysis
  • Thrombolytic Therapy / methods
  • Time-to-Treatment
  • Ventricular Septal Rupture* / diagnosis
  • Ventricular Septal Rupture* / etiology
  • Ventricular Septal Rupture* / mortality
  • Ventricular Septal Rupture* / therapy

Substances

  • Fibrinolytic Agents
  • Streptokinase